Image Guided Biopsy

PROCEDURE4 trials

Sponsors

Jonsson Comprehensive Cancer Center, City of Hope Medical Center, University of Washington

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate CarcinomaExtramedullary Disease in Multiple MyelomaMetastatic Prostate CarcinomaMetastatic Triple-Negative Breast CarcinomaMultiple MyelomaStage IV Prostate CancerStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8

Phase 1

Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy

RecruitingNCT05398302

Jonsson Comprehensive Cancer CenterCastration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8 +2

Start: 2024-04-26End: 2027-12-31Target: 30Updated: 2026-06-15

External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease

SuspendedNCT06572605

City of Hope Medical CenterExtramedullary Disease in Multiple Myeloma, Multiple Myeloma

Start: 2025-08-29End: 2030-01-18Target: 20Updated: 2026-09-10

Phase 2

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

RecruitingNCT07078604

University of WashingtonAnatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Start: 2026-03-24End: 2028-06-30Target: 20Updated: 2026-08-04

Unknown Phase

Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy

WithdrawnNCT03596710

Jonsson Comprehensive Cancer CenterCastration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer

Start: 2018-06-14End: 2022-06-14Updated: 2020-07-23

Related Papers

A phase II study of the DNA plasmid-based vaccine STEMVAC in patients with metastatic triple-negative breast cancer (mTNBC).

Journal of Clinical Oncology2026-05-28